Panobinostat OverviewPanobinostat (trade name Farydak /frdæk/ FAIR--dak) is a drug by Novartis for the treatment of various cancers. It is a hydroxamic acid and acts as a non-selective histone deacetylase inhibitor (pan-HDAC inhibitor). On 23 February 2015 it received FDA accelerated approval for use in patients with multiple myeloma, and on 28 August 2015 it was approved by the European Medicines Agency for the same use.[6&a...
Read more Panobinostat Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Panobinostat
Recent Panobinostat Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Capsule: 10mg, 15mg, 20mg
Other drugs which contain Panobinostat or a similar ingredient: (1 result)
- FARYDAK Panobinostat